Implantica publishes Interim Report January – March 2023 (Q1)
RefluxStop™ - Designed for a Revolution in the Care of Acid RefluxSignificant events in the first quarter of 2023
· RefluxStop™ is currently being launched in Scandinavia, with Ersta Hospital and Sundsvall Sjukhus in Sweden, the first centers committing to join our registry study. · Validated clinical data collection continues for RefluxStop™ with AKH Vienna presenting their results on their first RefluxStop™ patients at the Finnish Gastro Days Congress in Helsinki. · The first RefluxStop™ surgeries have been performed in Spain as we continue to prepare for the public tender